Novo Integrated Sciences, Inc. announced the Company's Board of Directors has appointed Mr. Robert Mattacchione, a majority stakeholder in Novo Integrated Sciences, as the Company's Chairman of the Board and Chief Executive Officer. Dr. Pierre Dalcourt, the outgoing Board Chairman remains as a member of the Board of Directors, along with the other remaining Board members, Christopher David and Michael Gaynor. Collectively, the four members of the Company's Board of Directors controls approximately 87% of the Company's issued and outstanding common shares.

Mr. Mattacchione is the co-founder of Novo Healthnet Limited, a wholly owned subsidiary of the Company (“NHL”). NHL was founded in 2013 to provide multi-dimensional primary healthcare services and products throughout Canada. Novo Integrated Sciences acquired NHL in 2017.